International News

Sanofi Teams Up With India to Make Cheap Antiretrovirals in South Africa

From CDC National Prevention Information Network

April 2, 2012

Under an arrangement announced Friday, French drugmaker Sanofi will partner with India's Hetero to manufacture low-cost antiretrovirals in South Africa. The move represents progress toward South Africa's goal of buying 80 percent of its ARVs from local sources, said Sanofi CEO Christopher Viehbacher. "There is a continuous supply shortage for critical medicines for HIV/AIDS. Only 50 percent of patients are able to receive treatment, and there is a real need for more locally manufactured and supplied affordable ARVs." To accommodate increased demand, Sanofi recently upgraded its factory north of Pretoria.

Back to other news for April 2012

Adapted from:
Agence France Presse
03.30.2012

No One Funding Model Is Sufficient to Ensure Availability of Life-Saving Drugs

First-Ever Compulsory License Issuance in India Could Have Implications for HIV Medication

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.

More on Generic/Discount HIV Drug Access in the Developing World

No comments have been made.

Add Your Comment:

(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

More on Generic/Discount HIV Drug Access in the Developing World

"You don't have to fight this fight by yourself." Watch Susan's Story >

More >>

TheBody.com App

Get Our Newsletters

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.